Philippines Pharmaceuticals and Healthcare Report Q4 2013

Date: August 21, 2013
Pages: 119
Price:
US$ 1,295.00
Publisher: Business Monitor International
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P73973A1DC4EN
Leaflet:

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI View: Rising healthcare expenditure will be one of the key drivers of pharmaceutical growth in the Philippines as the country's intention to provide universal healthcare coverage sets the stage for increased access to health and pharmaceutical services. In addition to improving access to healthcare, the country is also looking to boost efforts in research and medical tourism. If successful, this will boost Philippines's pharmaceutical business environment. A downside risk to our view is that the majority of the South East Asian countries are also looking to boost their efforts in these three functions, and the country will therefore have to compete for foreign investment.

Headline Expenditure Projections
  • Pharmaceuticals: PHP129.78bn (US$3.08bn) in total sales in 2012, rising to PHP134.21bn (US$3.25bn) in 2013; +3.4% in local currency terms and +5.7% in US dollar terms.
  • Healthcare: PHP455.15bn (US$10.79bn) in sales in 2012 rising to PHP511.55bn (US$12.38bn) in 2013; +12.4% in local currency terms and +14.8% in US dollar terms.
BMI Industry View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
  Table: Philippines Pharmaceutical Sales, Historical Data and Forecasts, 2009-2017
Healthcare Market Forecast
  Table: Philippines Healthcare Expenditure Trends, Historical Data and Forecasts, 2009-2017
  Table: Philippines Government Healthcare Expenditure Trends, Historical Data and Forecasts, 2009-2017
  Table: Philippines Private Healthcare Expenditure Trends, Historical Data and Forecasts, 2009-2017
Prescription Drug Market Forecast
  Table: Philippines Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017
Patented Drug Market Forecast
  Table: Philippines Patented Drug Market Indicators, Historical Data and Forecasts, 2009-2017
Generic Drug Market Forecast
  Table: Philippines Generics Drug Market Indicators, Historical Data and Forecasts, 2009-2017
OTC Medicine Market Forecast
  Table: Philippines Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts, 2009-2017
Pharmaceutical Trade
  Table: Philippines Pharmaceutical Trade Data And Forecasts (US$mn), 2009-2017
  Table: Philippines Pharmaceutical Trade Data And Forecasts (PHPmn), 2009-2017
Other Healthcare Data
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
Investment Boom On Course
External Risks Pertinent, But Not Overwhelming
Fundamentals In Place For Medium-Term Growth Pick-Up
  Table: Philippines - Economic Activity
Industry Risk Reward Ratings
Asia Pacific Risk/Reward Ratings
Philippines Risk Reward Ratings
  Table:   Table: Asia Pacific Pharmaceutical Risk/Reward Ratings, Q213
Market Overview
Industry Trends And Developments
Regulatory Development
  Table: History Of Food And Drugs Administration
  Table: Medicines Subject To March 31 2010 Government Mediated Access Price
Competitive Landscape
  Table: Pharmaceutical Industry Overview
  Table: Overview Of BnB, BNB and P100 Programme
  Table: Cost Of Generic Drugs In Philippines (PHP)
  Table: Number Of BnBs and BNBs In Selected Philippine Regions
Company Profile
Unilab
Pascual Laboratories
Pacific Pharma Generics
MediChem Pharmaceuticals
GlaxoSmithKline Philippines
Pfizer
Novartis
Merck & Co
Sanofi
Demographic Forecast
  Table: Philippines' Population By Age Group, 1990-2020 ('000)
  Table: Philippines' Population By Age Group, 1990-2020 (% of total)
  Table: Philippines' Key Population Ratios, 1990-2020
  Table: Philippines' Rural And Urban Population, 1990-2020
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology

Ask Your Question

Philippines Pharmaceuticals and Healthcare Report Q4 2013
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: